Epidemiology and risk factors for venous thrombosis.

PubWeight™: 1.90‹?› | Rank: Top 3%

🔗 View Article (PMC 2020806)

Published in Semin Hematol on April 01, 2007

Authors

Mary Cushman1

Author Affiliations

1: Department of Medicine, Thrombosis and Hemostasis Program, University of Vermont College of Medicine and Fletcher Allen Health Care, Burlington, VT, USA. mary.cushman@uvm.edu

Articles citing this

Triggers, targets and treatments for thrombosis. Nature (2008) 3.51

Cost-effectiveness of strategies for diagnosing pulmonary embolism among emergency department patients presenting with undifferentiated symptoms. Ann Emerg Med (2010) 2.19

Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood (2009) 2.07

Concomitant and antecedent deep venous thrombosis and cancer survival in male US veterans. Leuk Lymphoma (2011) 1.50

Factor VIII May Predict Catheter-Related Thrombosis in Critically Ill Children: A Preliminary Study. Pediatr Crit Care Med (2015) 1.44

Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health (2009) 1.18

Peripheral blood gene expression profiling for cardiovascular disease assessment. Genomic Med (2008) 1.18

Tissue factor and thrombosis: The clot starts here. Thromb Haemost (2010) 1.16

A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Genet Epidemiol (2013) 1.12

C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort. Thromb Haemost (2009) 1.11

Laparoscopic versus open appendectomy for the obese patient: a subset analysis from a prospective, randomized, double-blind study. Surg Endosc (2010) 1.05

American Heart Association's Life's Simple 7 and risk of venous thromboembolism: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. J Am Heart Assoc (2015) 1.03

Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms. Curr Opin Pulm Med (2009) 0.97

Venous thromboembolism risk factor assessment and prophylaxis. Phlebology (2010) 0.92

Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition? Hepatol Int (2010) 0.89

Combined magnetic resonance imaging of deep venous thrombosis and pulmonary arteries after a single injection of a blood pool contrast agent. Eur Radiol (2010) 0.87

Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study. BMC Psychiatry (2011) 0.85

Deep vein thrombosis prophylaxis in trauma patients. Thrombosis (2011) 0.85

A Possible Association of Diindolylmethane with Pulmonary Embolism and Deep Venous Thrombosis. Case Rep Med (2016) 0.82

Risk marker associations with venous thrombotic events: a cross-sectional analysis. BMJ Open (2014) 0.80

Coagulation and the vessel wall in pulmonary embolism. Pulm Circ (2013) 0.79

Colorectal cancer, comorbidity, and risk of venous thromboembolism: assessment of biological interactions in a Danish nationwide cohort. Br J Cancer (2015) 0.78

Correlates of in-hospital deaths among hospitalizations with pulmonary embolism: findings from the 2001-2008 National Hospital Discharge Survey. PLoS One (2012) 0.78

Hypoplasia of the inferior vena cava in a young man presenting with extensive deep venous thrombosis. BMJ Case Rep (2015) 0.78

Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis. Diabetes Res Clin Pract (2015) 0.77

ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer. Cancer Med (2015) 0.77

Prevention of venous thromboembolism in medical intensive care unit: a multicenter observational study in Korea. J Korean Med Sci (2014) 0.77

Circulating endothelial cells in patients with venous thromboembolism and myeloproliferative neoplasms. PLoS One (2013) 0.76

Myeloid p53 regulates macrophage polarization and venous thrombus resolution by inflammatory vascular remodeling in mice. Blood (2017) 0.76

Suprarenal stricture of the inferior vena cava with massive iliocaval and distal thromboses successfully treated with catheter-directed thrombectomy, thrombolysis and angioplasty. Int J Angiol (2009) 0.75

In vitro thrombolytic activity of Dhamasa (Fagonia arabica Linn.), Kushta (Saussurea lappa Decne.), and Guduchi (Tinospora cordifolia Thunb.). Ayu (2016) 0.75

Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case-control analysis. BMJ Open (2017) 0.75

Association between small intestinal bacterial overgrowth and deep vein thrombosis. Gastroenterol Rep (Oxf) (2016) 0.75

Inhibition of adenosine diphosphate-induced platelet aggregation by alpha-lipoic acid and dihydroquercetin in vitro. Indian J Pharmacol (2014) 0.75

Monthly haemostatic factor variability in women and men. Eur J Clin Invest (2014) 0.75

Association of vWA and TPOX polymorphisms with venous thrombosis in Mexican mestizos. Biomed Res Int (2014) 0.75

Prevalence of pulmonary embolism at autopsy among elderly patients in a Chinese general hospital. J Geriatr Cardiol (2016) 0.75

Deep venous thrombosis in a patient undergoing In-vitro fertilization with oocyte donation. J Hum Reprod Sci (2015) 0.75

Oral Thrombus: Report of 122 cases with clinically descriptive data. Med Oral Patol Oral Cir Bucal (2017) 0.75

Critical care of obese patients during and after spine surgery. World J Crit Care Med (2016) 0.75

Recurrent fracture of a recovery inferior vena cava filter with pulmonary migration. Yale J Biol Med (2012) 0.75

Deep Vein Thrombosis and Pulmonary Embolism in Liver Transplant Patients: Risks and Prevention. Transplant Direct (2016) 0.75

CETP Activity: A Link between Lipid Metabolism and Coagulation System. J Atheroscler Thromb (2016) 0.75

Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients. Cancer Invest (2016) 0.75

Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population. Eur J Epidemiol (2017) 0.75

Post-traumatic thrombo-embolic complications in polytrauma patients. Int Orthop (2015) 0.75

Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence. Eur J Epidemiol (2017) 0.75

Identification of target gene of venous thromboembolism in patients with lymphoma via microarray analysis. Oncol Lett (2017) 0.75

Articles cited by this

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 11.84

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43

The epidemiology of venous thromboembolism. Circulation (2003) 6.97

The long-term clinical course of acute deep venous thrombosis. Ann Intern Med (1996) 6.87

D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med (2006) 6.62

Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA (2005) 6.16

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet (1994) 5.45

Venous thrombosis: a multicausal disease. Lancet (1999) 5.41

Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med (2004) 4.38

Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med (2004) 3.74

Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost (2006) 3.49

Estrogen plus progestin and risk of venous thrombosis. JAMA (2004) 3.46

Severe pulmonary embolism associated with air travel. N Engl J Med (2001) 3.43

An association between atherosclerosis and venous thrombosis. N Engl J Med (2003) 3.39

D-dimer levels and risk of recurrent venous thromboembolism. JAMA (2003) 3.30

Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet (2006) 3.25

Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med (2002) 3.15

Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med (2001) 3.07

Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA (2005) 3.04

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98

High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med (2000) 2.86

Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial. Blood (2006) 2.78

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77

Increasing trends in waist circumference and abdominal obesity among US adults. Obesity (Silver Spring) (2007) 2.68

Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost (2002) 2.44

Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood (2002) 2.41

An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med (2000) 2.28

Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet (1997) 2.20

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA (1997) 1.94

A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood (2002) 1.86

Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med (1998) 1.86

Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost (2003) 1.80

Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med (2004) 1.78

The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med (1997) 1.75

Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA (2006) 1.72

Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost (2004) 1.70

Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost (2005) 1.66

Obesity as a risk factor in venous thromboembolism. Am J Med (2005) 1.66

D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost (2006) 1.62

Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time. J Thromb Haemost (2006) 1.58

Incidence of air travel-related pulmonary embolism at the Madrid-Barajas airport. Arch Intern Med (2003) 1.57

Analysis of occurrence of venous thromboembolic disease in the four seasons. Am J Cardiol (2004) 1.56

Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism. Am J Hematol (2002) 1.51

Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. J Thromb Haemost (2006) 1.46

Prospective evaluation of health-related quality of life in patients with deep venous thrombosis. Arch Intern Med (2005) 1.43

eThrombosis: the 21st century variant of venous thromboembolism associated with immobility. Eur Respir J (2003) 1.40

The post-thrombotic syndrome: current knowledge, controversies, and directions for future research. Blood Rev (2002) 1.38

Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. J Thromb Haemost (2006) 1.33

Travel-related venous thrombosis: results from a large population-based case control study (MEGA study). PLoS Med (2006) 1.27

The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. J Thromb Haemost (2003) 1.27

Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. J Thromb Haemost (2006) 1.25

Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation (1995) 1.24

Fatal pulmonary embolism in hospitalised medical patients. J Clin Pathol (1997) 1.24

Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med (2003) 1.23

Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. Circulation (2006) 1.14

The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost (2005) 1.12

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. Lancet (1999) 1.07

Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost (2005) 1.06

Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haematol (2006) 1.05

The impact of venous thrombosis on quality of life. Thromb Res (2004) 1.00

D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study. Thromb Haemost (2002) 0.97

Inherited risk factors for venous thrombosis. Hematology Am Soc Hematol Educ Program (2005) 0.97

Epidemiology of venous thromboembolism in a Chinese population. Br J Surg (2004) 0.97

Relation of three genetic traits to venous thrombosis in an African-American population. Am J Epidemiol (1998) 0.95

Comparison of the Villalta and Ginsberg clinical scales to diagnose the post-thrombotic syndrome: correlation with patient-reported disease burden and venous valvular reflux. J Thromb Haemost (2006) 0.94

Family history for venous thromboembolism and the risk for recurrence. Am J Med (2006) 0.93

Hyperhomocysteinemia and venous thromboembolism. Semin Thromb Hemost (2006) 0.93

Update on factor V Leiden association with venous thromboembolism in the LITE Study. Blood (2007) 0.89

Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. J Thromb Haemost (2006) 0.88

Minor events and the risk of deep venous thrombosis. Thromb Haemost (2000) 0.88

Effect of age on the incidence of venous thromboembolism after major surgery. J Thromb Haemost (2004) 0.88

Incidence of deep vein thrombosis in hospitalized Chinese medical patients is similar to that in western populations. Thromb Res (2006) 0.87

Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations. Am J Med Genet (1997) 0.86

Strenuous sport activities involving the upper extremities increase the risk of venous thrombosis of the arm. J Thromb Haemost (2005) 0.85

Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients. Br J Haematol (2005) 0.82

Management of thrombophilia: who to screen? Pathophysiol Haemost Thromb (2005) 0.82

Prevention of venous thromboembolism. Semin Thromb Hemost (2006) 0.81

Thrombophilia screening: a matter of debate. Neth J Med (2004) 0.78

Cancer and venous thromboembolism. Semin Thromb Hemost (2006) 0.77